Skip to main content

News

Silvercorp Extends Proxy Deadline, Softens Board Nomination Rules

Image
Silvercorp Extends Proxy Deadline, Softens Board Nomination Rules

Vancouver – – September 30, 2026 -- Silvercorp Metals Inc. (TSX: SVM) (NYSE American: SVM) has extended its shareholder proxy voting deadline to September 30, 2026 at 4:00 p.m. Pacific time, after approving a further revision to a special resolution governing amendments to the Company's corporate Articles ahead of its annual general and special meeting scheduled for October 2, 2026.

Company narrows information it can demand from director nominees

Silvercorp has amended Article 16, which governs how shareholders nominate individuals for election to the Board. Having initially proposed limiting the information required to assess a nominee's independence, the Company has now gone further, removing its ability to request any nominee information beyond items specifically enumerated in Article 16, paragraph 4. A redline of the proposed changes was filed on SEDAR+ on September 29, 2026 under "Other Securityholder Documents."

Milwaukee Tool Joins Skilled Trades Alliance, Eyes $200M Workforce Spend

Image
Milwaukee Tool Joins Skilled Trades Alliance, Eyes $200M Workforce Spend

Brookfield, Wis. – September 30, 2026 -- Milwaukee Tool has joined the Alliance for America's Skilled Trades and projects its cumulative U.S. workforce development investment will exceed $200 million by 2030, based on spending since 2010 and plans through the decade's end.

Milwaukee Tool backs more than 16,000 apprentices annually across the country

The company currently supports over 16,000 apprentices enrolled in skilled trades programs, working with more than 1,300 training centers and 25 national union and non-union partners nationwide.

Netwrix: 31% of Healthcare Orgs Hit by Unauthorized Identity Access

Image
Netwrix: 31% of Healthcare Orgs Hit by Unauthorized Identity Access

Frisco, Texas – September 30, 2026 -- Thirty-one percent of healthcare organizations experienced unauthorized identities accessing sensitive data in the past year, compared with 24% across other industries, according to new healthcare findings from Netwrix's 2026 Data and Identity Security Report. Among healthcare organizations that suffered an incident, 33% reported costs exceeding $250,000, versus 21% in other sectors.

Healthcare ranks last among 16 industries on Active Directory confidence

Only 14% of healthcare organizations said they are fully confident their Active Directory environments are free of privilege escalation risks, compared with 26% across all industries surveyed. Eighty-six percent lack full confidence in their AD security, the lowest ranking among the 16 industries with sufficient survey representation for comparison.

Arrowfly Launches AI for Engineers Platform, Sets 2027 Conference

Image
Arrowfly Launches AI for Engineers Platform, Sets 2027 Conference

Cleveland – September 30, 2026 -- Arrowfly has launched AI for Engineers, a year-round platform combining a dedicated news desk, an annual conference, original research, and an advisory board for engineers applying artificial intelligence across design, manufacturing, robotics, medtech, and energy work.

Arrowfly taps a 2.1 million-reader network to anchor the new initiative

The program draws on Arrowfly's more than 20 flagship engineering brands, which collectively reach 2.1 million verified industry readers, 29 million website visitors, 1.6 million email subscribers, and generate 202 million monthly impressions. More than 30,000 engineering and technical professionals have already engaged with AI-related webinars, newsletters, and editorial content across Arrowfly's engineering portfolio.

Lilly's EBGLYSS Hits Primary Endpoint in Phase 3b Hand-Foot Eczema Trial

Image
Lilly's EBGLYSS Hits Primary Endpoint in Phase 3b Hand-Foot Eczema Trial

Indianapolis – September 30, 2026 -- Eli Lilly and Company (NYSE: LLY) said its EBGLYSS (lebrikizumab-lbkz) monotherapy met the primary and secondary endpoints of the Phase 3b ADtouch study at Week 16, with more than half of treated patients achieving clear or almost clear skin on hands and feet (HF-IGA 0/1), the company disclosed ahead of the European Academy of Dermatology and Venereology Congress in Vienna, running Sept. 30-Oct. 3.

Trial enrolled 221 patients with moderate-to-severe hand and foot atopic dermatitis

The randomized, double-blind, placebo-controlled ADtouch trial (NCT06921759) assigned 221 adults and adolescents 1:1 to EBGLYSS 250 mg or placebo every two weeks over 16 weeks, following an initial loading dose. Participants had an inadequate response to topical therapies and applied moisturizer throughout the study.

Knowles Launches A-Series Attenuators Covering DC to 20 GHz

Image
Knowles Launches A-Series Attenuators Covering DC to 20 GHz

Itasca, Illinois – September 30, 2026 -- Knowles Corporation (NYSE:KN) has introduced its new ATT A-Series Attenuators, expanding its RF portfolio to position the company as a one-stop source for high-performance RF signal chain components.

New attenuators deliver DC-20 GHz coverage in a compact SMT package

The A-Series uses precision thin-film resistor technology on a ceramic substrate, measuring just 0.080" x 0.065" x 0.012" (2.03 x 1.65 x 0.30 mm). The product line offers standard attenuation values from 0 dB to 20 dB with a power handling rating up to 6.5 W CW at 100°C and an operating temperature range of -55°C to +125°C.

TGE Net Profit Jumps 9.9x on Hotel Acquisition Spree in H1 2026

Paris – – September 30, 2026 -- The Generation Essentials Group (NYSE: TGE; LSE: TGE) reported net profit of US$22.8 million for the six months ended June 30, 2026, a 9.9-fold increase driven by an aggressive expansion of its global hotel portfolio.

Revenue climbs 35.8% as hospitality segment surges 59.8%

Revenue from contracts with customers rose to US$30.8 million in the first half of 2026, up 35.8% year-on-year. The hotel operations, hospitality, and VIP services segment expanded 59.8%, becoming the primary growth driver following the acquisition and integration of four hotel properties in New York, Perth, Kuala Lumpur, and London.

EPS jumps 366.7% to US$0.56 as balance sheet expands to US$1.8 billion

Earnings per share increased 366.7% to US$0.56. Total assets stood at US$1.8 billion, equivalent to US$37.2 per share, while net asset value reached US$932.5 million, or US$19.2 per share.

In-Flight Entertainment & Connectivity Market to Hit $13.2B by 2031

Image
In-Flight Entertainment & Connectivity Market to Hit $13.2B by 2031

Delray Beach, Fla. – September 30, 2026 -- The global in-flight entertainment and connectivity (IFEC) market is set to grow from $9.50 billion in 2026 to $13.20 billion by 2031, a 6.8% compound annual growth rate, according to a new forecast from MarketsandMarkets.

Airlines accelerate WiFi and streaming upgrades to meet passenger demand

Rising passenger expectations for connected air travel are driving airlines to replace legacy in-flight entertainment equipment with satellite-based and hybrid connectivity systems. Increasing use of personal devices and demand for reliable in-flight internet are pushing carriers toward cloud-based platforms and personalized digital services, alongside onboard retail and advertising offerings.

SUANNUTRA Localizes Lemon Verbena Supply Chain in Valencia, Spain

Image
SUANNUTRA Localizes Lemon Verbena Supply Chain in Valencia, Spain

Madrid – September 30, 2026 -- SUANNUTRA SA has relocated cultivation of lemon verbena, a key botanical input for its branded ingredients, from South America to farms in Valencia, Spain, aiming to secure a more resilient and traceable supply chain.

SUANNUTRA shifts lemon verbena sourcing from the Andes to Valencia farms

The plant, native to South America and traditionally used by Andean healers as a digestive aid and antispasmodic remedy, now anchors three of SUANNUTRA's branded ingredients: Metabolaid®, RelaxPLX®, and Elissara®. "Growing it locally with full control from planting to final product reinforces our commitment to responsible botanical sourcing," said Jaime Durán Sanz, Chief Business Officer for SUANNUTRA.

Doseology Sciences Names Interim CEO/CFO, Adds TSX-Nasdaq Finance Veteran to Board

Image
Doseology Sciences Names Interim CEO/CFO, Adds TSX-Nasdaq Finance Veteran to Board

Kelowna, BC – September 30, 2026 -- Doseology Sciences Inc. (CSE: MOOD, OTCQB: DOSEF, FSE: VU70) has appointed Kareem Baalbaki as interim CEO, interim CFO and director, alongside Jeremy Wright as a new board director, replacing outgoing CEO Chris Jackson and CFO Chris Cherry, who have both resigned.

Baalbaki scaled a Canadian CPG operator's revenue fifteenfold before joining Doseology

Baalbaki previously served as Chief Supply Chain Officer at Revive Superfoods, where he helped grow the frozen CPG platform's annual revenue from approximately $10 million to $150 million. The Toronto-based executive holds more than a decade of operations and supply-chain experience, including restructuring underperforming businesses and advising boards on governance and organizational design. He holds a Master of Science in International Business from the University of Lincoln in the United Kingdom.